Literature DB >> 29032891

Modulating the immune system through nanotechnology.

Tamara G Dacoba1, Ana Olivera1, Dolores Torres2, José Crecente-Campo3, María José Alonso4.   

Abstract

Nowadays, nanotechnology-based modulation of the immune system is presented as a cutting-edge strategy, which may lead to significant improvements in the treatment of severe diseases. In particular, efforts have been focused on the development of nanotechnology-based vaccines, which could be used for immunization or generation of tolerance. In this review, we highlight how different immune responses can be elicited by tuning nanosystems properties. In addition, we discuss specific formulation approaches designed for the development of anti-infectious and anti-autoimmune vaccines, as well as those intended to prevent the formation of antibodies against biologicals.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune disease; Immune system; Nanotechnology; Stimulation; Tolerance; Vaccine

Mesh:

Year:  2017        PMID: 29032891      PMCID: PMC5774666          DOI: 10.1016/j.smim.2017.09.007

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  276 in total

1.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigen.

Authors:  B Frisch; S Muller; J P Briand; M H Van Regenmortel; F Schuber
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

4.  Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.

Authors:  Keiji Hirota; Taizo Hasegawa; Hideyuki Hinata; Fuminori Ito; Hiroyuki Inagawa; Chie Kochi; Gen-Ichiro Soma; Kimiko Makino; Hiroshi Terada
Journal:  J Control Release       Date:  2007-02-01       Impact factor: 9.776

5.  Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.

Authors:  Giuseppe Cappellano; Abiy Demeke Woldetsadik; Elisabetta Orilieri; Yogesh Shivakumar; Manuela Rizzi; Fabio Carniato; Casimiro Luca Gigliotti; Elena Boggio; Nausicaa Clemente; Cristoforo Comi; Chiara Dianzani; Renzo Boldorini; Annalisa Chiocchetti; Filippo Renò; Umberto Dianzani
Journal:  Vaccine       Date:  2014-08-20       Impact factor: 3.641

6.  Construction of biologically functional bacterial plasmids in vitro.

Authors:  S N Cohen; A C Chang; H W Boyer; R B Helling
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

Review 7.  The mechanism of action of MF59 - an innately attractive adjuvant formulation.

Authors:  D T O'Hagan; G S Ott; E De Gregorio; A Seubert
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

8.  Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.

Authors:  Antonella Carambia; Barbara Freund; Dorothee Schwinge; Oliver T Bruns; Sunhild C Salmen; Harald Ittrich; Rudolph Reimer; Markus Heine; Samuel Huber; Christian Waurisch; Alexander Eychmüller; David C Wraith; Thomas Korn; Peter Nielsen; Horst Weller; Christoph Schramm; Stefan Lüth; Ansgar W Lohse; Joerg Heeren; Johannes Herkel
Journal:  J Hepatol       Date:  2015-01-21       Impact factor: 25.083

9.  Towards programming immune tolerance through geometric manipulation of phosphatidylserine.

Authors:  Reid A Roberts; Timothy K Eitas; James D Byrne; Brandon M Johnson; Patrick J Short; Karen P McKinnon; Shannon Reisdorf; J Christopher Luft; Joseph M DeSimone; Jenny P Ting
Journal:  Biomaterials       Date:  2015-08-20       Impact factor: 12.479

10.  A polymer/oil based nanovaccine as a single-dose immunization approach.

Authors:  Sara Vicente; Belen Diaz-Freitas; Mercedes Peleteiro; Alejandro Sanchez; David W Pascual; Africa Gonzalez-Fernandez; Maria J Alonso
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more
  20 in total

Review 1.  Nanoparticle-hydrogel superstructures for biomedical applications.

Authors:  Yao Jiang; Nishta Krishnan; Jiyoung Heo; Ronnie H Fang; Liangfang Zhang
Journal:  J Control Release       Date:  2020-05-26       Impact factor: 9.776

2.  Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection.

Authors:  Hongzhao Li; Robert W Omange; Binhua Liang; Nikki Toledo; Yan Hai; Lewis R Liu; Dane Schalk; Jose Crecente-Campo; Tamara G Dacoba; Andrew B Lambe; So-Yon Lim; Lin Li; Mohammad Abul Kashem; Yanmin Wan; Jorge F Correia-Pinto; Michael S Seaman; Xiao Qing Liu; Robert F Balshaw; Qingsheng Li; Nancy Schultz-Darken; Maria J Alonso; Francis A Plummer; James B Whitney; Ma Luo
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 3.  Role of lymph node stroma and microenvironment in T cell tolerance.

Authors:  Vikas Saxena; Lushen Li; Christina Paluskievicz; Vivek Kasinath; Asher Bean; Reza Abdi; Christopher M Jewell; Jonathan S Bromberg
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

Review 4.  Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases.

Authors:  Lampouguin Yenkoidiok-Douti; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2020-01-12

Review 5.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

Review 6.  miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy.

Authors:  Naveed Sabir; Tariq Hussain; Syed Zahid Ali Shah; Antonio Peramo; Deming Zhao; Xiangmei Zhou
Journal:  Front Microbiol       Date:  2018-03-29       Impact factor: 5.640

7.  Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen.

Authors:  Tamara G Dacoba; Robert W Omange; Hongzhao Li; José Crecente-Campo; Ma Luo; Maria Jose Alonso
Journal:  ACS Nano       Date:  2019-04-23       Impact factor: 15.881

Review 8.  Supramolecular Self-Assembled Nanostructures for Cancer Immunotherapy.

Authors:  Zichao Huang; Wantong Song; Xuesi Chen
Journal:  Front Chem       Date:  2020-05-25       Impact factor: 5.221

9.  Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors.

Authors:  Tamara G Dacoba; Clément Anfray; Francesco Mainini; Paola Allavena; María José Alonso; Fernando Torres Andón; José Crecente-Campo
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

10.  Evaluation of a new Argovit as an antiviral agent included in feed to protect the shrimp Litopenaeus vannamei against White Spot Syndrome Virus infection.

Authors:  Carlos R Romo-Quiñonez; Ana R Álvarez-Sánchez; Pindaro Álvarez-Ruiz; Maria C Chávez-Sánchez; Nina Bogdanchikova; Alexey Pestryakov; Claudio H Mejia-Ruiz
Journal:  PeerJ       Date:  2020-02-27       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.